Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Alzheimer Disease 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Dementia 2Cognitive Dysfunction 2Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sleep Deprivation 1REM Sleep Behavior Disorder 1Psychological Well-Being 1Pain 1Otolaryngeal Cancer 1Neoplasm Metastasis 1Idiopathic Hypersomnia 1Depression 1Combat Disorders 1Chronobiology Disorders 1Cancer Pain 1Breast Neoplasms 1Anxiety Disorders 1Agnosia 1

Interventions

Fentanyl 27Analgesia 23Morphine 20Acupuncture Therapy 18Surveys and Questionnaires 16Oxycodone 16Zoledronic Acid 15Acetaminophen 14Therapeutics 13Radiotherapy 13Psychiatric Rehabilitation 13Ketamine 13Methadone 11Lidocaine 11Hydromorphone 11Bupivacaine 11nabiximols 10Ibandronic Acid 10Ropivacaine 9Early Intervention, Educational 7Analgesics, Opioid 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Electroencephalography × Clear all
NCT06644573 2025-05-28

PSHW

PROSOMNIA Sleep Health & Wellness

Phase 1 Not yet recruiting
100 enrolled

Cancer Pain, Psychological Well-Being, Alzheimer Disease, Anxiety Disorders, Combat Disorders, Depression, Sleep Initiation and Maintenance Disorders, Pain, Sleep Deprivation, Stress Disorders, Post-Traumatic, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, REM Sleep Behavior Disorder, Chronobiology Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡